Of all the claims made about NMN, its effect on blood sugar is one of the few backed by a properly controlled human trial. In 2021, researchers at Washington University School of Medicine published results in Science showing that NMN improved muscle insulin sensitivity in women with prediabetes. That study remains the strongest single piece of human evidence for NMN and metabolic health. Here is what it found, what it did not find, and what it means if you are thinking about supplementing.
Why Blood Sugar and NAD+ Are Connected
Insulin sensitivity describes how well your cells respond to insulin, the hormone that moves glucose out of your bloodstream and into muscle and liver tissue. When cells become resistant to insulin, blood sugar stays elevated, the pancreas compensates by producing more insulin, and over years this trajectory can end in type 2 diabetes.
NAD+ sits close to the centre of this process. It is a required cofactor for the enzymes that run glucose metabolism, and it fuels sirtuins, the proteins that regulate insulin signalling and mitochondrial function. NAD+ levels fall with age, and they fall further in people with obesity and metabolic dysfunction. The hypothesis behind NMN supplementation is simple: restore NAD+, and you support the machinery that keeps glucose metabolism running properly.
The Washington University Trial
The study, led by Dr. Mihoko Yoshino and colleagues in the lab of Dr. Shin-ichiro Imai, enrolled 25 postmenopausal women with prediabetes who were overweight or obese. Participants took either 250mg of NMN or a placebo every day for 10 weeks. Neither the participants nor the researchers knew who was in which group until the end.
The headline result: muscle insulin sensitivity improved by roughly 25% in the NMN group, measured with the hyperinsulinemic-euglycemic clamp, the gold-standard technique for quantifying insulin action. The researchers also saw increased activation of insulin signalling proteins (AKT and mTOR) inside muscle tissue, and upregulation of genes involved in muscle remodelling.
For context, a 25% improvement is in the same range as what metformin or a structured 12-week exercise programme typically produces in similar populations. If you are curious how NMN compares with the most prescribed diabetes drug, we cover that in detail in NMN and metformin.
What the Trial Did Not Show
Honest reporting matters here, because supplement marketing often stretches this study past what it says. The trial found no significant change in:
- Fasting blood glucose or HbA1c
- Liver or adipose (fat tissue) insulin sensitivity
- Body weight or body fat percentage
- Blood pressure or blood lipids
In other words, NMN made muscle respond better to insulin, but it did not lower blood sugar readings over 10 weeks in this group. That is not surprising. Muscle insulin sensitivity is an early, upstream marker. Changes in HbA1c usually take longer and larger effects to show up. But it does mean NMN is not a treatment for diabetes, and nobody should present it as one.
Supporting Evidence from Other Studies
The Washington University trial does not stand entirely alone:
- A 2023 randomised trial in overweight adults found 12 weeks of NMN lowered post-meal glucose response at higher doses
- Japanese studies have confirmed oral NMN reliably raises blood NAD+ levels within weeks, with good safety at doses up to 1250mg/day
- In aged and diabetic mice, NMN restored glucose tolerance and insulin secretion, the original findings that motivated the human work
- NMN improved aerobic capacity in amateur runners, relevant because exercise itself is a powerful insulin sensitiser
The full picture of human research, including what remains unproven, is covered in our guide to NMN clinical trials.
- 250mg/day NMN for 10 weeks improved muscle insulin sensitivity by ~25% in prediabetic women
- The effect size was comparable to metformin or a 12-week exercise programme
- Fasting glucose, HbA1c and body weight did not change in the trial
- NMN supports metabolic health; it is not a diabetes treatment
- Benefits likely take 8 to 10 weeks of consistent daily use
Practical Guidance If You Want to Try NMN
The trial used 250mg daily, and most commercial products, including AlphaVita, provide 500mg per capsule, which sits comfortably within the range shown to be safe and effective in human studies. See our NMN dosage guide for a fuller breakdown.
- Take it daily and give it time. The insulin sensitivity effect appeared after 10 weeks of consistent use, not days.
- Pair it with movement. Muscle is where the effect happens. Resistance training and walking after meals amplify insulin sensitivity through independent pathways.
- Do not drop prescribed medication. If you take metformin or any glucose-lowering drug, talk to your doctor before adding NMN.
- Buy tested material. Look for third-party purity testing above 98% and a published Certificate of Analysis. Underdosed or degraded NMN is common in the UK market.
If weight management is part of your motivation, note that NMN itself did not reduce weight in trials. What it may do is support the metabolic machinery that makes diet and exercise work better, a distinction we explore in NMN and weight loss.
AlphaVita NMN 500mg
Pharmaceutical-grade NMN at the full clinical dose. Third-party tested, UK-formulated, free delivery.
Shop AlphaVita NMN →